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1. Introduction 
Hepatic ribosome preparations from diabetic rats 
have a lower polysome content than those from normal 
animals, and show reduced protein synthetic activity 
in cell-free systems [l-4]. More detailed analysis of 
the effects of diabetes has been carried out with skeletal 
muscle, in which similar, but more pronounced, 
changes occur [S], and it seems likely that in this tissue 
insulin exerts translational control on protein synthesis 
at the level of peptide chain initiation [6, 71. 
In the studies with liver [l-4], the cell-free systems 
which were used consisted of recombined ribosome 
and cell sap fractions. In such systems, most of the 
amino acid incorporation obtained represents elongation 
of existing nascent peptide chains, and the extent of 
initiation of new chains is small [8]. However, crude 
hepatic postmitochondrial supematants (PMS)* are 
twice as active in amino acid incorporation as more 
highly fractionated systems [9], and the ribosomes in 
the crude system show some ability to re-initiate on to 
endogenous mRNA [ 10-121. The data in the present 
report show that PMS preparations from livers of 
diabetic rats show a reduced ability to incorporate 
amino acids into protein. This difference between 
extracts from diabetic and control animals is almost 
completely abblished in the presence of inhibitors of 
peptide chain initiation. 
*Abbreviations: 
PMS : postmitochondrial supernatant; 
Poly(1): polyinosinic acid; 
ATA : aurintricarboxylic acid. 
North-Holland Atblishing Company - Amsterdam. 
2. Materials and methods 
Male, Porton-type Wistar rats were obtained from 
SACI, Braintree, UK, and were maintained on Oxoid 
pellets. Diabetes was induced in rats of 90-100 g body 
weight by intravenous administration of streptozotocin 
(kindly provided by Upjohn Ltd, Kalamazoo, Mich., 
USA) in citrate buffer, pH 4.5 at a dose of 100 mg/kg. 
The animals were used 5 days later, and were fed ad 
libitum throughout. 
Livers were homogenised in 3 vol of TKM buffer 
(50 mM Tris, 100 mM KCl, 5 mM magnesium acetate, 
6 mM mercaptoethanol) containing 0.25 M sucrose. 
PMS fractions were prepared by centrifugation of 
homogenates at 10 000 g for 10 min. Immediately 
before incubation, PMS samples were passed down 
columns of Sephadex G-25 (Pharmacia), equilibrated 
with TKM buffer, to remove endogenous amino acids. 
For assay of cell-free synthesis, PMS samples were 
diluted 1 in 3 with assay medium such that the final 
concentrations of components in the incubation 
mixture were as follows: 50 mM Tris-HCl (pH 7.6), 
100 mM KCl, 5 mM magnesium acetate, 6 mM mercap- 
toethanol, 1 mM ATP, 0.2 mM GTP, 5 mM creatine 
phosphate, creatine phosphokinase (50 pg/ml), 
[14C]leucine (diluted with unlabelled leucine to a 
specific activity of 165 Ci/mol) or [ 14C] phenylalanine 
(diluted with unlabelled phenylalanine to a specific 
activity of 167 Ci/mol) 0.42 &i/ml, and the 19 other 
amino acids, unlabelled, at 30 /.&I each. After incuba- 
tion at 37”C, samples were pipetted on to Whatman 
3MM filter paper discs, and incorporation of radio- 
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activity into protein was assayed by the method of 
Mans and Novelli [ 13]. Counting efficiency was 
about 50%. 
ATP, GTP, creatine phosphate, creatine phospho- 
kinase and polyinosinic acid (Poly(I) were obtained 
from Boehringer Mannheim GmbH. Poly(I) solutions 
(in water) were heated to 90°C and cooled immediately 
before use. Aurintricarboxylic acid (ATA) was a gift 
from the late Professor A. Korner. L-[U-14C]phenyl - 
alanine (490-513 Ci/mol) and L-[U-14C] leucine 
(331 Ci/mol) were obtained from the Radiochemicai 
Centre, Amersham, UK, and unlabelled amino acids 
from Sigma (London) Chemical Co. Cycloheximide 
was bought from Koch-Light Ltd., UK. 
3. Results and discussion 
PMS preparations from livers of diabetic rats were 
Table 1 
Influence of diabetes and insulin treatment on incorporation 
of amino acids into protein of postmitochondrial supernatants 
and the effect of inhibitors of peptide chain initiation. 
Inhibitor Treatment of animals 
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Fig. 1 a). Inhibition of [ 14 C] phenylalanine incorporation i to 
protein by postmitochondrial supernatant systems from normal 
and diabetic animals by increasing concentrations of poly(I). 
Samples were prepared and incubated as described in the 
Materials and methods ection. Incubations were for 10 min. 
(c~y---o) PMS from normal rats; (; ~, ;) PMS from diabetic 
rats. b) Effect of diabetes on protein synthesis n the PMS 
system in the presence of increasing concentrations of poly(I). 
Incubations were carried out as described above. 
Normal Diabetic Insulin 
treated 
Incorporation of
phenylalanine 
(mol phe/mol 
ribosomes) 
Incorporation 
of leucine 
(mol leu/mol 
ribosomes) 
Inhibition by 
poly(I) (%): 
Phenylalanine 
incorporation 
Leucine 
incorporation 
None 1.14 0.76 1.38 
Poly(1) 0.37 0.35 0.44 
None 1.65 1.01 1.32 
Poly(I) 0.50 0.43 0.44 
ATA 1.02 0.88 0.97 
67.5 53.9 68.1 
69.6 57.4 66.6 
Incubations were carried out for 10 min under the conditions 
described inMaterials and methods. Poly(I) was present at a 
concentration f 500 ug/ml, and ATA at 1 X 10 -4 M. Each 
sample was prepared from the pooled livers of 4-6 animals. 
Insulin-treated diabetic animals were injected subcutaneously 
with protamine zinc insulin (4 units) twice daily for 2 days 
before the experiment, and with soluble insulin (5 units) 2 hr 
before death. 
30-40% less active than samples from normal rats in 
incorporating [ 14C] phenylaianine or [ 14 C ] leucine into 
protein (table 1). This result was also obtained with 
[14C] tyrosine (result not shown). Insulin treatment of  
the diabetic rats increased the protein synthetic activity 
of the PMS, in most cases restoring it completely to 
normal. 
In order to see whether diabetes lowered activity 
by reducing the extent of chain initiation in vitro, 
incubations were carried out in the presence of the 
initiation inhibitors poly(I) and ATA. Under these 
conditions amino acid incorporation is due solely to 
completion of pre-existing nascent peptides. Poly(I) 
is thought o bind ribosomes available for initiation, 
thus preventing them from attaching to translatable 
messenger RNA's [14], and recent evidence shows that, 
in the reticulocyte lysate at least, this inhibitor does 
not affect rates of chain elongation [15]. ATA, on the 
other hand, acts by preventing attachment of 40 S 
ribosomal subunits to mRNA [16]. It can be seen from 
table 1 that in the presence of either inhibitor the 
reduction in incorporation due to diabetes was almost 
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Fig. 2. Time course of incorporation of [ 14C]leucine into 
protein in the presence and absence of poly(I) by PMS samples 
from (a) normal and (b) diabetic rats. Incubations were 
carried out as described in Materials and methods. Poly(I) was 
present at a final concentration of 500 fig/ml. (o-+-c) 
Poly(1) absent; (- ) Poly(1) present. 
abolished. It is not clear why the extent of inhibition 
with ATA was less than that with Poly(1). Probably 
ATA was added at a suboptimal concentration, 
although that used was similar to the maximum found 
by others to inhibit initiation in this system without 
affecting elongation as well [ 121. It is difficult to com- 
pare concentrations of this compound used in different 
laboratories, as preparations vary, in their contamination 
with impurities. Moreover, the effective concentration 
of the inhibitor can be influenced by the concentration 
of protein present [ 171. However, it is clear that the 
results with ATA confirm the conclusion that in this 
system the effect of diabetes is exerted primarily at 
the level of chain initiation. 
Fig. l(a) shows the responses of the system to in- 
creasing concentrations of Poly(1). At saturating con- 
centrations of the polynucleotide (greater than 
400 kg/ml), incorporation by extracts from normal or 
insulin treated rats was inhibited by 66-70%, and 
that from diabetic rats by just over 50% in a 10 min 
incubation. In the absence of new initiation each active 
ribosome completes the synthesis of half a nascent 
protein chain on average. Hence, in this time, 1.5 
rounds of translation occur in the normal preparation 
and 1 round in the diabetic, in the absence of poly(1). 
b 
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Fig. 3. Time course of incorporation of [ 14C]leucine into 
total acid precipitable (m) peptide and into protein 
released from the ribosomes (- ). PMS samples were 
incubated as described in Materials and methods. At appro- 
priate intervals, samples were removed from the incubation 
mixture and rapidly mixed with an equal volume of 0.8 mM 
leucine containing 2% Triton X-100 and 200 bg/ml cyclo- 
heximide at 0°C. Radioactivity in protein was measured in 
samples of this mixture before and after removal of ribosomes 
by centrifugation at 157 000 g for 1.5 hr. a) PMS from 
normal rats; b) PMS from diabetic rats. 
In exhibiting saturation, poly(I) differs from initiation 
inhibitors known to affect peptide chain elongation at 
high concentrations [18, 191. Fig. l(b) shows how the 
difference in activity bet%ween extracts from normal 
and diabetic animals diminished as the concentration 
of poly(1) was increased. At a saturating concentration 
of the inhibitor the extent of incorporation by the 
diabetic samples was at least 90% of the control value 
and in some experiments was the same as the control. 
Fig. 2 shows the time course of incorporation in 
the PMS system in the presence and absence of poly(1). 
In the absence of the inhibitor, the rate of incorpora- 
tion of leucine during the first 2 min of incubation was 
0.33 mol/mol ribosomes/min with the normal extract 
and 0.23 mol/mol ribosomes/min with the diabetic. 
This is comparable to the rate of protein synthesis 
reported for this system by Richardson et al. [9]. The 
inhibitory effect of poly(I) begins to be apparent after 
1.5-2 min of incubation, suggesting that the average 
translation time for the proteins being synthesised is 
3-4 min at 37°C assuming that the ribosomes are 
evenly spaced along the messenger. There appears to 
be no difference in this respect between samples from 
normal and diabetic animals, suggesting that diabetes 
does not affect the rate of chain elongation in this 
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system. This suggestion is supported by estimations 
of the average translation time based on the kinetics 
of incorporation of radioactivity into total and released 
peptides, as described by other workers for cell culture 
[20] and tissue incubation [21] systems (fig. 3). The 
appearance of radioactivity in protein released from 
the ribosomes showed a lag of about 1.5 min before 
linear kinetics were obtained in PMS systems from 
either normal or diabetic rats, indicating an average 
translation time of about 3 min in each case. Unlike 
the situation with whole cells [20, 211, the rate of in- 
corporation into released protein was considerably 
slower than the total incorporation rate throughout 
the period of active protein synthesis. It therefore 
appears that the termination and release process is 
somewhat impaired in the cell-free incubation system. 
However, sucrose gradient analysis of the incubation 
mixture shows that the polysomes disaggregate rapidly 
[22], indicating that “queueing” of ribosomes awaiting 
release from messenger RNA does not occur. Presum- 
ably nascent peptides remain attached to many 
ribosomes after they are released from the messenger 
RNA. 
The observation that diabetes does not appear to, 
affect the translation time in the PMS indicates that it 
has little or no effect on the rate of chain elongation 
in liver. Since the disease does result in a substantial 
reduction of protein synthesis in this system, one must 
conclude, by exclusion, that the effect is mainly on 
chain initiation. Thus the kinetic measurements con- 
firm the conclusions of the inhibitor studies. Polysome 
profiles indicate that the rate of initiation relative to 
elongation is reduced in vivo, since the PMS from 
diabetic rats contains smaller polysomes 1221. Possible 
mechanisms for the effect on initiation include decreased 
availability of functional mRNA, an intrinsic defect 
in ribosomes from diabetic animals, which makes them 
less able to take part in initiation, or a decrease in 
availability or activity of initiation factors. Further 
work is required to distinguish between these alterna- 
tives. 
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